A detailed history of Bell Investment Advisors, Inc transactions in Haleon PLC stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 271 shares of HLN stock, worth $2,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares
271
Previous 271 -0.0%
Holding current value
$2,544
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$7.57 - $8.37 $635 - $703
-84 Reduced 23.66%
271 $2,000
Q4 2022

Feb 08, 2023

BUY
$5.96 - $8.06 $441 - $596
74 Added 26.33%
355 $2,000
Q3 2022

Nov 09, 2022

BUY
$5.63 - $7.5 $1,582 - $2,107
281 New
281 $2,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.